Search for: "IN RE ROCHE MOLECULAR SYSTEMS"
Results 1 - 19
of 19
Sorted by Relevance
|
Sort by Date
13 Jul 2011, 5:54 am
Roche Molecular Systems, Inc. held that under the Patent Act an inventors owns his or her invention in the first instance and only a valid and binding assignment agreement is effective to transfer ownership from the inventor. [read post]
9 Jun 2011, 2:38 am
Supreme Court opinions can be tricky to parse, but this week's Stanford University v Roche Molecular Systems, Inc. has a drafting lesson for inventors, universities and private employers. [read post]
9 Jun 2011, 2:00 am
Roche Molecular Systems, Inc., 583 F.3d 832 (2010). [5] Slip. [read post]
9 Jun 2011, 2:00 am
Roche Molecular Systems, Inc., 583 F.3d 832 (2010). [5] Slip. [read post]
20 Jan 2022, 4:43 am
Roche Wants to Patent Molecular Detection and Counting Using Nanopores U.S. patent application, US20220011292, discloses a method to quantify target analytes, including nucleic acids and polypeptides using nanopore detectable barcodes. [read post]
5 Jun 2011, 1:12 pm
Roche Molecular Systems, Inc. [read post]
9 Jun 2011, 9:21 am
Roche Molecular Systems (although the Federal Circuit reached the same conclusion the Supreme Court did about the Bayh-Dole Act in an earlier case).Today the Court affirmed in Microsoft v. i4i Limited Partnership, agreeing with the Federal Circuit’s longstanding position that under § 282 of the Patent Act, the invalidity of a patent must be proved by clear and convincing evidence. [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology… [read post]
16 Feb 2012, 8:07 am
Roche Molecular Systems, Inc. - This case involved the interpretation of two competing assignments executed before the invention was conceived or reduced to practice. [read post]
16 Feb 2012, 8:07 am
Roche Molecular Systems, Inc. - This case involved the interpretation of two competing assignments executed before the invention was conceived or reduced to practice. [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) US: Obvious-type double patenting and… [read post]
25 Oct 2010, 9:15 am
.): This post has been modified to include petitions that have been re-listed for the Conference of October 29. [read post]
1 Jul 2021, 8:48 am
Roche Molecular Systems, Inc., 563 U.S. 776 (2011) (re-affirming assignment priority rules in cases of conflicting patent assignments).DissentOn the other hand, if the approach announced by the dissent takes hold, or is extended to other doctrinal areas, the resulting legal changes could be felt on a massive scale. [read post]
10 Mar 2011, 2:39 pm
· Limit enhanced damages, In re Seagate, 497 F. 3d 1360 (Fed. [read post]
2 Jun 2011, 12:33 pm
Roche Molecular Systems. [read post]
3 Jan 2011, 9:45 pm
Medical Device: MEDICAL DEVICE SUPPLIER ISN'T 'HEALTH CARE PROVIDER', Orthopedic Res. v. [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge), (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
14 Aug 2011, 9:11 am
Levine, “Fraud and Errors Fuel Research Journal Retractions,” (August 10, 2011); Murat Cokol, Fatih Ozbay, and Raul Rodriguez-Esteban, “Retraction rates are on the rise,” 9 European Molecular Biol. [read post]
